Local treatment of brain tumors with targeted chimera cytotoxic proteins

Cancer Investigation

Volumn 20, Issue 5-6, 2002, Pages 801-809

  Debinski, Waldemar ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; CYTOTOXIC FACTOR; CYTOTOXIN; CYTOTOXIN A; CYTOTOXIN B; DENILEUKIN DIFTITOX; DIPHTHERIA TOXIN; HORMONE; IMMUNOTOXIN; INTERLEUKIN 13; MONOCLONAL ANTIBODY; PSEUDOMONAS EXOTOXIN; RICIN A; TRANSFERRIN; UNCLASSIFIED DRUG; LIGAND; PROTEIN; TRANSFERRIN RECEPTOR;

ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CHIMERA; CLINICAL TRIAL; CONJUGATE; DRUG DELIVERY SYSTEM; HUMAN; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TUMOR GROWTH; TUMOR LOCALIZATION; DRUG EFFECT; IMMUNOLOGY;

ASTROCYTOMA; BACTERIAL TOXINS; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOTOXINS; LIGANDS; PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 0036053691     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120003545     Document Type: Review

References (76)

1. Levin, V.A.; Sheline, G.H.; Gutin, P.H. Neoplasms of the Central Nervous System. Cancer: Principles and Practice of Oncology, 3rd Ed.; J. B. Lippincott Company: Philadelphia, 1989; 1557-1611.
2. Kleihues, P.; Soylemezoglu, F.; Schauble, B.; Scheithauer, B.W.; Burger, P.C. Histopathology, Classification, and Grading of Gliomas. Glia 1995, 15, 211-221.
3. Davis, F.G.; Freels, S.; Grutsch, J.; Barlas, S.; Brem, S. Survival Rates in Patients with Primary Brain Tumors Stratified by Patient Age and Tumor Histological Type: an Analysis Based on Surveillance, Epidemiology, and End Results (SEER) Data, 1973-1991. J. Neurosurg. 1998, 88, 1-10.
4. Marshall, E. "Reports from the Front" Science, 267, 1995, 1414.
5. Olson, M.E.; Chernik, N.L.; Posner, J.B. Infiltration of the Leptomeninges by Systemic Cancer. Arch. Neurol. 1974, 30, 122-136.
6. Brem, S.; Cotran, R.; Folkman, J. Tumor Angiogenesis: a Quantitative Method for Histologic Grading. J. Natl Cancer Inst. 1972, 48, 347-356.
7. Ji, Y.; Powers, S.K.; Brown, J.T.; Miner, R. Characterization of the Human Invasion Area in the Rat Intracerebral Glioma. J. Neuro-Oncol. 1996, 30, 189-197.
8. Keles, G.E.; Anderson, B.; Berger, M.S. The Effect of Extent of Resection on Time to Tumor Progression and Survival in Patients with Glioblastoma Multiforme of the Cerebral Hemisphere. Surg. Neurol. 1999, 52, 371-379.
9. Leibel, S.A.; Scott, C.B.; Loeffler, J.S. Contemporary Approaches to the Treatment of Malignant Gliomas with Radiation Therapy. Semin. Oncol. 1994, 21, 198-219.
10. Lesser, G.J.; Grossman, S. The Chemotherapy of High-Grade Astrocytomas. Semin. Oncol. 1994, 21, 220-235.
11. Herlyn, M.; Menrad, A.; Koprowski, H. Structure, Function, and Clinical Significance of Human Tumor Antigens. J. Natl Cancer Inst. 1990, 82, 1883-1889.
12. Debinski, W.; Karlsson, B.; Lindholm, L.; Siegall, C.B.; Willingham, M.C.; FitzGerald, D.; Pastan, I. Monoclonal Antibody C242-Pseudomonas Exotoxin A: A Specific and Potent Immunotoxin with Anti-tumor Activity on a Human Colon Cancer Xenograft in Nude Mice. J. Clin. Investig. 1992, 90, 405-411.
13. Libermann, T.A.; Nusbaum, H.R.; Razon, N.; Kris, R.; Lax, I.; Soreq, H. Amplification, Enhanced Expression and Possible Rearrangement of EGF Receptor Gene in Primary Human Brain Tumours of Glial Origin. Nature 1985, 313, 144-147.
14. Debinski, W.; Siegall, C.B.; FitzGerald, D.; Pastan, I. Substitution of Foreign Protein Sequences into a Chimeric Toxin Composed of Transforming Growth Factor α and Pseudomonas Exotoxin. Mol. Cell. Biol. 1991, 11, 1751-1753.
15. Debinski, W.; Puri, R.K.; Kreitman, R.J.; Pastan, I. A Wide Range of Human Cancers Express Interleukin 4 (IL4) Receptors that can be Targeted with Chimeric Toxin Composed of IL4 and Pseudomonas Exotoxin. J. Biol. Chem. 1993, 268, 14065-14070.
16. Debinski, W.; Obiri, N.I.; Pastan, I.; Puri, R.K. A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4. J. Biol. Chem. 1995, 270, 16775-16780.
17. Wikstrand, C.J.; McLendon, R.E.; Friedman, A.H.; Bigner, D.D. Cell Surface Localization and Density of the Tumor-Associated Variant of the Epidermal Growth Factor Receptor, EGFRvIII. Cancer Res. 1997, 57, 4130-4140.
18. Moscatello, D.K.; Holgado-Madruga, M.; Godwin, A.K.; Ramirez, G.; Gunn, G.; Zoltick, P.W.; Biegel, J.A.; Hayes, R.L.; Wong, A.J. Frequent Expression of a Mutant Epidermal Growth Factor Receptor in Multiple Human Tumors. Cancer Res. 1995, 55, 5536-5539.
19. Kunwar, S.; Pai, L.H.; Pastan, I. Cytotoxicity and Antitumor Effects of Growth Factor-Toxin Fusion Proteins on Human Glioblastoma Multiforme Cells. J. Neurosurg. 1993, 79, 569-576.
20. Martell, L.A.; Agrawal, A.; Ross, D.A.; Muraszko, K.M. Efficacy of Transferrin Receptor-Targeted Immunotoxins in Brain Tumor Cell Lines and Pediatric Brain Tumors. Cancer Res. 1993, 53, 1348-1353.
21. Morrison, R.S.; Yamaguchi, F.; Bruner, M.M.; Tang, M.; McKeehan, W.; Berger, M.S. Fibroblast Growth Factor Receptor Gene Expression and Immunoreactivity are Elevated in Human Glioblastoma Multiforme. Cancer Res. 1994, 54, 2794-2799.
22. Tureci, O.; Sahin, U.; Zwick, C.; Neumann, F.; Pfreundschuh, M. Exploitation of the Antibody Repertoire of Cancer Patients for the Identification of Human Tumor Antigens. Hybridoma 1999, 18, 23-28.
23. Debinski, W.; Gibo, D.M. Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-Associated Cancer/Testis Antigen. Mol. Med. 2000, 6, 440-449.
24. Moolten, F.L.; Cooperband, S.R. Selective Destruction of Target Cells by Diphtheria Toxin Conjugated to Antibody Directed Against Antigen on the Cells. Science 1970, 169 (July), 68-70.
25. Pastan, I.; Chaudhary, V.K.; Fitzgerald, D. Recombinant Toxins as Novel Therapeutic Agents. Annu. Rev. Biochem. 1992, 61, 331-354.
26. Pai, L.H.; Wittes, R.; Setser, A.; Willingham, M.C.; Pastan, I. Treatment of Advanced Solid Tumors With Immunotoxin LMB-1: An Antibody Linked to Pseudomonas Exotoxin. Nature Med. 1996, 2, 350-353.
27. Laske, D.W.; Youle, R.J.; Oldfield, E.H. Tumor Regression with Regional Distribution of the Targeted Toxin TF-CRM107 in Patients with Malignant Brain Tumors. Nature Med. 1997, 3, 1362-1368.
28. 486-IL-2). J. Biol. Chem. 1990, 265, 11885-11889.
29. Caraglia, M.; Budillon, A.; Vitale, G.; Lupoli, G.; Tagliaferri, P.; Abbruzzese, A. Modulation of Molecular Mechanisms Involved in Protein Synthesis Machinery as a New Tool for the Control of Cell Proliferation. Eur. J. Biochem. 2000, 267, 3919-3936.
30. Laske, D.W.; Ilercil, O.; Akbasak, A.; Youle, R.J.; Oldfield, E.H. Efficacy of Direct Intratumoral Therapy with Targeted Protein Toxins for Solid Human Gliomas in Nude Mice. J. Neurosurg. 1994, 80, 520-526.
31. Recht, L.D.; Griffin, T.W.; Raso, V.; Salimi, A.R. Potent Cytotoxicity of an Antihuman Transferrin Receptor-Ricin A-Chain Immunotoxin on Human Glioma Cells In Vitro. Cancer Res. 1990, 50, 6696-6700,
32. Debinski, W.; Obiri, N.I.; Powers, S.K.; Pastan, I.; Puri, R.K. Human Glioma Cells Over-Express Receptor for Interleukin 13 and Are Extremely Sensitive to a Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin. Clin. Cancer Res. 1995, 1, 1253-1258.
33. Vitetta, E.S.; Fulton, R.J.; May, R.D.; Till, M.; Uhr, J.W. Redesigning Nature's Poison to Create Anti-tumor Reagents. Science 1987, 238, 1098-1104.
34. Youle, R.J.; Neville, D.M. Anti-thy 1.2 Monoclonal Antibody Linked to Ricin is a Potent Cell-Type-Specific Toxin. Proc. Natl Acad. Sci. USA 1980, 77, 5483-5486.
35. Ross, B.D.; Kim, B.; Davidson, B.L. Assessment of Ganciclovir Toxicity to Experimental Intracranial Gliomas Following Recombinant Adenoviral-Mediated Transfer of the Herpes Simlex Virus Thymidine Kinase Gene by Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy. Clin. Cancer Res. 1995, 1, 651-657.
36. Ram, Z.; Culver, K.W.; Oshiro, E.M.; Viola, J.J.; DeVroom, H.L.; Otto, E.; Long, Z.; Chiang, Y.; McGarrity, G.J.; Muul, L.M.; Katz, D.; Blaese, R.M.; Oldfield, E.H. Therapy of Malignant Brain Tumors by Intratumoral Implantation of Retroviral Vector-Producing Cells. Nature Med. 1997, 3, 1354-1361.
37. Gomez-Manzano, C.; Fueyo, J.; Kyritsis, A.P.; Steck, P.A.; Roth, J.A.; McDonnell, T.J.; Steck, K.D.; Levin, V.A.; Yung, W.K.A. Adenovirus-Mediated Transfer of the P53 Gene Produces Rapid and Generalized Death of Human Glioma Cells via Apoptosis. Cancer Res. 1996, 56, 694-699, Advances in Brief.
38. Debinski, W.; Miner, R.; Obiri, N.I.; Puri, R.K. Receptor for IL 13 does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on human Glioma Cells. J. Biol. Chem. 1996, 271, 22428-22433.
39. Keppler-Hafkemeyer, A.; Brinkmann, U.; Pastan, I. Role of Caspases in Immunotoxin-Induced Apoptosis of Cancer Cells. Biochemistry 1998, 37 (48), 16934-16942.
40. Keppler-Hafkemeyer, A.; Kreitman, R.J.; Pastan, I. Apoptosis Induced by Immunotoxins used in the Treatment of Hematologic Malignancies. Int. J. Cancer 2000, 87, 86-94.
41. Debinski, W.; Pastan, I. Recombinant F(ab) C242-Pseudomonas Exotoxin, But Not the Whole Antibody-Based Immunotoxin, Causes Regression of a Human Colorectal Tumor Xenograft. Clin. Cancer Res. 1995, 1, 1015-1022.
42. Debinski, W.; Pastan, I. Monovalent Immunotoxin Containing Truncated Form of Pseudomonas Exotoxin as Potent Antitumor Agent. Cancer Res. 1992, 52, 5379-5385,
43. Reiter, Y.; Pastan, I, Recombinant Fv Immunotoxins and Fv Fragments as Novel Agents for Cancer Therapy and Diagnosis. Trends Biotechnol. 1998, 16, 513-520.
44. Iglewski, B.H.; Kabat, D. NAD-Dependent Inhibition of Protein Synthesis by Pseudomonas aeruginosa Toxin. Proc. Natl Acad. Sci., USA 1975, 72, 2284-2288.
45. Pardridge, William M., (Ed.) Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology; Cambridge University Press: Cambridge, England, 1998.
46. Huwyler, J.; Dafang, W.; Pardridge, W.M. Brain Drug Delivery of Small Molecules Using Immunoliposomes. Proc. Natl Acad. Sci. USA 1996, 93, 14164-14169.
47. Long, D.M, Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors. J. Neurosurg. 1970, 32, 127-144.
48. Wersall, P.; Ohlsson, I.; Biberfeld, P.; Collins, V.; von Krusenstjerna; Larsson, S.; Mellstebt, H.; Boethims, J. Intratumoral Infusion of the Monoclonal Antibody, mAb 425, Against the Epidermal-Growth-Factor Receptor in Patients with Advanced Malignant Glioma. Cancer Immunol. Immunother. 1997, 44, 157-164.
49. Griffon-Etienne, G.; Boucher, Y.; Jain, R.K.; Suite, H.D. Effects of Needle Insertion in Tumors on Interstitial Fluid Pressure. Microvasc. Res. 1997, 54, 174-177,
50. Baluna, R.; Rizo, J.; Gordon, B.E.; Ghetie, V.; Vitetta, E.S. Evidence for a Structural Motif in Toxins and Interleukin-2 that May Be Responsible for Binding to Endothelial Cells and Initiating Vascular Leak Syndrome. Proc. Natl Acad. Sci. USA 1999, 96, 3957-3962.
51. Connor, J.R.; Fine, R.E. The Distribution of Transferrin Immunoreactivity in the Rat Central Nervous System. Brain Res. 1986, 368, 319-328.
52. Hill, J.M.; Ruff, M.R.; Weber, R.J.; Pert, C.B. Transferrin Receptor in Rat Brain: Neuropeptide-Like Pattern and Relationship to Iron Distribution. Proc. Natl Acad. Sci. USA 1985, 82, 4553-4557.
53. Debinski, W.; Slagle, B.; Gibo, D.M.; Powers, S.K.; Gillespie, G.Y. Expression of a Restrictive Receptor for Interleukin 13 Is Associated with Glial Transformation. J. Neuro-Oncol. 2000, 48, 103-111.
54. Zovickian, J.; Johnson, V.G.; Youle, R.J. Potent and Specific Killing of Human Maligant Brain Tumor Cells by an Anti-transferrin Receptor Antibody-Ricin Immunotoxin. J. Neurosurg. 1987, 66, 850-861.
55. Recht, L.; Torres, C.O.; Smith, T.W.; Raso, V.; Griffin, T.W. Transferrin Receptor in Normal and Neoplastic Brain Tissue: Implications for Brain-Tumor Immunotherapy. J. Neurosurg. 1990, 72, 941-945.
56. Martell, L.A.; Agrawal, A.; Ross, D.A.; Muraszko, K.M. Efficacy of Transferrin Receptor-Targeted Immunotoxins in Brain Tumor Cell Lines and Pediatric Brain Tumors. Cancer Res. 1993, 53, 1348-1353.
57. Oldfield, E.H. Convection-Enhanced Delivery Brain Tumor Therapy: Advantages and Disadvantages. 14th International Conference on Brain Tumor Research and Therapy, Asheville, NC, May 2001.
58. Debinski, W.; Miner, R.; Gibo, D.; Puri, R.K. Novel Way to Increase Targeting Specificity to a Human Glioblastoma-Associated Receptor for Interleukin 13. Int. J. Cancer 1998, 76, 547-551.
59. Humphrey, P.A.; Wong, A.J.; Vogelstein, B.; Friedman, H.S.; Werner, M.H. ; Bigner, D.D.; Bigner, S.H. Amplification and Expression of the Epidermal Growth Factor Receptor Gene in Human Glioma Xenografts. Cancer Res. 1988, 48, 2231-2238.
60. Wikstrand, C.J.; Hale, L.P.; Batra, S.K.; Hill, L.; Humphrey, P.A.; Kurpad, S.N.; McLendon, R.E.; Moscatello, D.; Pegram, C.N.; Reist, C.J.; Traweek, T.; Wong, A.J.; Zalutsky, M.R.; Bigner, D.D. Monoclonal Antibodies Against EGFRvIII are Tumor Specific and React with Breast and Lung Carcinomas and Malignant Gliomas. Cancer Res. 1995, 55, 3140-3148.
61. Lorimer, I.A.; Wikstrand, C.J.; Batra, S.K.; Bigner, D.D.; Pastan, I. Immunotoxins that Target an Oncogenic Mutant Epidermal Growth Factor Receptor Expressed in Human Tumors. Clin. Cancer Res. 1995, 1, 859-864.
62. Minty, A.; Chalon, P.; Derocq, J.M.; Dumont, X.; Guillemot, J.C.; Kaghad, M.; Labit, C.; Leplatois, P.; Liauzun, P.; Miloux, B.; Minty, C.; Casellas, P. ; Loison, G.; Lupker, J.; Shire, D.; Ferrara, P.; Caput, D. Interleukin-13 is a New Human Lymphokine Regulating Inflammatory and Immune Responses. Nature 1993, 362, 248-251.
63. McKenzie, A.N.J.; Culpepper, J.A.; De Waal Malefyt, R.; Briere, F.; Punnonen, J.; Aversa, G.; Sato, A.; Dang, W.; Cocks, B.G.; Menon, S.; De Vries, J.E.; Banchereau, J.; Zurawski, G. Interleukin 13, a T-Cell-Derived Cytokine that Regulates Human Monocyte and B-Cell Function. Proc. Natl Acad. Sci. USA. 1993, 90, 3735-3739.
64. Debinski, W.; Pastan, I. An Immunotoxin with Increased Activity and Homogeneity Produced by Reducing the Number of Lysine Residues in Recombinant Pseudomonas Exotoxin. Bioconjug. Chem. 1994, 5, 40-46.
65. Debinski, W. An Immune Regulatory Cytokine Receptor and Glioblastoma Multiforme: An Unexpected Link. Crit. Rev. Oncogen. 1998, 9, 255-268.
66. Debinski, W.; Gibo, D.M.; Kealiher, A.; Puri, R.K. Novel Anti-brain Tumor Cytotoxins Specific for Cancer Cells. Nature Biotcchnol. 1998, 16, 449-453.
67. Debinski, W.; Gibo, D.M.; Hulet, S.W.; Connor, J.R.; Gillespie, G.Y. Receptor for Interleukin 13 is a Marker and Therapeutic Target for Human High-Grade Gliomas. Clin. Cancer Res. 1999, 5, 985-990.
68. Debinski, W.; Gibo, D.M.; Slagle, B.; Powers, S.K.; Gillespie, G.Y. Receptor for Interleukin 13 is Abundantly and Specifically Over-expressed in Patients with Glioblastoma Multiforme. Int. J. Oncol. 1999, 15, 481-486.
69. Debinski, W.; Nash, K.T.; Thompson, J.P. Rationally Designed Multiply Mutated Interleukin 13-Based Cytotoxins for the Treatment of Gliomas. Neuro-Oncology 2000, 2, 259.
70. Mintz, A.; Debinski, W. Cancer Genetics/Epigenetics and the X Chromosome: Possible New Links for Malignant Glioma Pathogenesis and Immune-Based Therapies. Crit. Rev. Oncogen. 2000, 11, 77-95.
71. Caput, D.; Laurent, P.; Kaghad, M.; Lelias, J.-M.; Lefort, S.; Vita, N.; Ferrara, P. Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α Chain. J. Biol. Chem. 1996, 271, 16921-16926.
72. Hilton, D.J.; Zhang, J.-G.; Metcalf, D.; Alexander, W.S.; Nicola, N.A.; Wilson, T.A. Cloning and Characterization of a Binding Subunit of the Interleukin 13 Receptor That is Also a Component of the Interleukin 4 Receptor. Proc. Natl Acad. Sci. USA 1996, 93, 497-501.
73. Zurawski, S.M.; Vega, F., Jr.; Huyghe, B.; Zurawski, G. Receptors for Interleukin-13 and Interleukin-4 Are Complex and Share a Novel Component That Functions in Signal Transduction. EMBO J. 1993, 12, 2663-2670.
74. Guo, J.; Apiou, F.; Mellerin, M.-P.; Lebeau, B.; Jacques, Y.; Minvielle, S. Chromosome Mapping and Expression of the Human Interleukin-13 Receptor. Genomics 1997, 42, 141-145.
75. Donaldson, D.D.; Whitters, M.J.; Fitz, L.J.; Neben, T.Y.; Finnerty, H.; Henderson, S.L.; O'Hrajr, R.M.; Beier, D.R.; Turner, K.J.; Wood, C.R.; Collins, M. The Murine IL-13 Receptor Alpha 2: Molecular Cloning, Characterization and Comparison with Murine IL-13 Receptor Alpha 1. J. Immunol. 1998, 161, 2317-2324.
76. Walter, K.A.; Cahan, M.A.; Gur, A.; Tyler, B.; Hilton, J.; Colvin, O.M.; Burger, P.C.; Domb, A.; Brem, H. Interstitial Taxol Delivered from a Biodegradable Polymer Implant Against Experimental Malignant Glioma. Cancer Res. 1994, 54, 2207-2212.